Ana B. Pavel - Concepedia

Author

Ana B. Pavel

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

A. Pavel, A.B. Pavel, Ana B Pavel, Ana B. Pavel, Ana Brandusa Pavel

Publications

805

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai University of Mississippi Rockefeller University Magna Graecia University University of California Davis Medical Center

About

Ana B. Pavel is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, dermatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	309
2	Immunology	3	3	76
3	Allergy	2	2	54
4	Pharmacology	1	1	184
5	Asthma	1	1	32

Ana B. Pavel

Publications

766

Citations

H-Index

Page 1

	Year	Citations
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Brett King, Emma Guttman‐Yassky, Elena Peeva, Journal of the American Academy of Dermatology Backgroundalopecia AreataPharmacologyClinical TrialsClinical DermatologyPlacebo-controlled Study	2021	184
Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares, Allergy	2021	133
Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality Ana B. Pavel, Jacob W. Glickman, James R. Michels, Frontiers in Genetics	2021	101
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata Yael Renert‐Yuval, Ana B. Pavel, Ester Del Duca, Allergy	2022	49
Vascular inflammation in moderate‐to‐severe atopic dermatitis is associated with enhanced Th2 response A. Villani, Ana B. Pavel, Jianni Wu, Allergy	2021	42
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata Jacob W. Glickman, Celina Dubin, Dante Dahabreh, Allergy	2021	41
Age of onset defines two distinct profiles of atopic dermatitis in adults Paola Facheris, Joel Corrêa da Rosa, Angel D. Pagan, Allergy	2023	39
Mapping atopic dermatitis and anti–IL-22 response signatures to type 2–low severe neutrophilic asthma Yusef Badi, Ana B. Pavel, Stelios Pavlidis, Journal of Allergy and Clinical Immunology AsthmaInflammationAnti–il-22 Response SignaturesAllergyAtopic Dermatitis	2021	32
Proteomic characterization of atopic dermatitis blood from infancy to adulthood Ester Del Duca, Yael Renert‐Yuval, Ana B. Pavel, Journal of the American Academy of Dermatology Atopic DermatitisMedicineImmunologyAutoimmunityDermatology	2023	31
A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis Stephen C. Piscitelli, Ana B. Pavel, Kimberly McHale, Journal of Investigative Dermatology Phase 1BTopical CerdulatinibSingle-center TrialAtopic DermatitisSkin Allergy	2021	27

Page 1